Issued Patents All Time
Showing 1–25 of 72 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12357598 | Treatment of neurodevelopmental disorders | Sung-hee Hwang, Jun Yang, Kenji Hashimoto | 2025-07-15 |
| 12251379 | Methods of inhibiting formation of alpha synuclein aggregates | Sung-hee Hwang, Kenji Hashimoto, Qian Ren | 2025-03-18 |
| 12006355 | Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif) | Natalia Vasylieva, Jiexian Dong, Christophe Morisseau, Dean R. Madden | 2024-06-11 |
| 11987542 | Co-crystal of sorafenib derivatives and process for preparation thereof | Sung-hee Hwang, Karen Wagner, Cynthia B. McReynolds | 2024-05-21 |
| 11873288 | Inhibitors for soluble epoxide hydrolase (sEH) and fatty acid amide hydrolase (FAAH) | Sean Kodani | 2024-01-16 |
| 11723929 | Methods of improving cell-based therapy | Nipavan Chiamvimonvat, Padmini Sirish | 2023-08-15 |
| 11690837 | Methods of improving cell-based therapy | Nipavan Chiamvimonvat | 2023-07-04 |
| 11572347 | Orally available sEH/PDE4 dual inhibitors | Rene Bloecher, Christophe Morisseau, Yang Kevin Xiang, Karen Wagner, Todd Harris +2 more | 2023-02-07 |
| 11426385 | Methods of improving cancer chemotherapy | Sung-hee Hwang, Ralph William de Vere White, Chong-xian Pan, Hongyong Zhang, Paul Henderson +3 more | 2022-08-30 |
| 11225514 | Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif) | Natalia Vasylieva, Jiexian Dong, Christophe Morisseau, Dean R. Madden | 2022-01-18 |
| 11123311 | Methods of treating mental disorders | Christophe Morisseau, Jun Yang, Kenji Hashimoto | 2021-09-21 |
| 11001783 | Synthesis and use of ω-hydroxylated polyunsaturated fatty acids | Guodong Zhang, Sung-hee Hwang, Weicang Wang | 2021-05-11 |
| 10858338 | Inhibitors for soluble epoxide hydrolase (SEH) and fatty acid amide hydrolase (FAAH) | Sean Kodani | 2020-12-08 |
| 10813894 | Methods of inhibiting pain | Ahmet Bora Inceoglu, Fawaz G. HAJ, Ahmed BETTAIEB | 2020-10-27 |
| 10758511 | Stable analogs of CYP450 lipid metabolites and inhibitors of soluble epoxide hydrolase | Kip M. Connor, Eiichi Hasegawa, Kin Sing Lee | 2020-09-01 |
| 10689595 | Synthesis and use of omega-hydroxylated polyunsaturated fatty acids | Guodong Zhang, Sung-hee Hwang, Weicang Wang | 2020-06-23 |
| 10449182 | Sorafenib derivatives as p21 inhibitors | Robert H. Weiss, Hiromi Wettersten, Sung-hee Hwang | 2019-10-22 |
| 10383835 | Treatment of inflammatory disorders in non-human mammals | Alonso G. P. Guedes, Christophe Morisseau | 2019-08-20 |
| 10377744 | Potent soluble epdxide hydrolase inhibitors | Kin Sing Lee, Ahmet Bora Inceoglu | 2019-08-13 |
| 10369141 | Methods of improving cell-based therapy | Nipavan Chiamvimonvat | 2019-08-06 |
| 10322118 | Compounds and methods for inhibiting Cif virulence factor | Dean R. Madden, Christopher D. Bahl, Christophe Morisseau | 2019-06-18 |
| 10101324 | Non-competitive immunoassays to detect small molecules using nanopeptamers | Gualberto Gonzalez-Sapienza, Andres Gonzalez-Techera, Lucia Vanrell, Gabriel Lassabe | 2018-10-16 |
| 9850207 | Substituted piperidines as soluble epdxide hydrolase inhibitors | Kin Sing Lee, Bora Inceoglu, Karen Wagner | 2017-12-26 |
| 9296693 | Acyl piperidine inhibitors of soluble epoxide hydrolase | Tristan Rose, Christophe Morisseau, Kin Sing Lee | 2016-03-29 |
| 9119837 | Use of sEH inhibitors as analgesics | Ahmet Bora Inceoglu | 2015-09-01 |